News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GE Healthcare Presents Parkinsonian Syndromes and Alzheimer’s Disease Research Data and Introduces New Products at Society of Nuclear Medicine and Molecular Imaging Annual Meeting


5/30/2013 8:12:09 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

GE Healthcare today announced that results from three company studies utilizing DaTscan™ (Ioflupane I 123 Injection) in Parkinsonian Syndromes or the investigational imaging agent [18F]flutemetamol will be presented at the 2013 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI 2013) taking place in Vancouver from June 8-11.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES